MMP2 and lung carcinoma: Lung cancer patients exhibit abnormal TRPM7 expression, which activates the Hsp90α/uPA/MMP2 signaling pathway and induces pluripotent transcription factors, thereby enhancing the metastatic phenotype of lung cancer [114].